Biohaven BHVN
NYSE BHVN
$15.69 -0.17 (-1.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Biohaven (BHVN) Other Non-Current Liabilities (2021 - 2026)

Biohaven (BHVN) posted Other Non-Current Liabilities of $4.6 million for Q1 2026, down 0.59% sequentially from $4.6 million in Q4 2025, and down 94.84% YoY from $88.3 million in Q1 2025.

Analysis

Biohaven (BHVN) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Biohaven has reported Other Non-Current Liabilities for 6 years, with the latest figure at $4.6 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 94.84% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (down 94.84% YoY) and the FY2025 annual result came in at $4.6 million, down 1.72% from the prior year.
  • Other Non-Current Liabilities declined to $4.6 million in Q1 2026 per BHVN's latest filing, from $4.6 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $268.3 million in Q3 2025 and troughed at $2.2 million in Q4 2023.
  • A 5-year average of $43.9 million and a median of $4.6 million in 2026 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2025 and 2026: Other Non-Current Liabilities jumped 5849.32% in 2025, then tumbled 94.84% in 2026.
  • Over 5 years, Other Non-Current Liabilities stood at $2.4 million in 2022, then dropped by 6.85% to $2.2 million in 2023, then soared by 107.71% to $4.7 million in 2024, then decreased by 1.72% to $4.6 million in 2025, then retreated by 0.59% to $4.6 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $4.6 million, $4.6 million, and $268.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Biohaven 2.37 Bn 2.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.49 Mn
Mar 31, 2026 4.56 Mn
Dec 31, 2025 4.58 Mn
Sep 30, 2025 4.60 Mn
Jun 30, 2025 4.64 Mn
Mar 31, 2025 4.61 Mn
Dec 31, 2024 4.66 Mn
Sep 30, 2024 12.32 Mn
Jun 30, 2024 12.18 Mn
Mar 31, 2024 3.41 Mn
Dec 31, 2023 2.25 Mn
Sep 30, 2023 2.27 Mn
Jun 30, 2023 2.52 Mn
Mar 31, 2023 2.50 Mn
Dec 31, 2022 2.41 Mn
Sep 30, 2022 7.00 Mn
Dec 31, 2021 2.64 Mn